An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
Public ClinicalTrials.gov record NCT02762500. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to evaluate the efficacy and safety of LYC-30937-EC given orally once daily in subjects with active ulcerative colitis (UC) defined as a total Mayo score (TMS) of 4-11 inclusive, with an endoscopic score of ≥ 2 and a rectal bleeding score of ≥ 1 at screening.
Study identification
- NCT ID
- NCT02762500
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 124 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2016
- Primary completion
- Apr 30, 2018
- Completion
- Apr 30, 2018
- Last update posted
- Apr 1, 2019
2016 – 2018
United States locations
- U.S. sites
- 26
- U.S. states
- 13
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Lycera Investigational Site | Little Rock | Arkansas | 72212 | — |
| Lycera Investigational Site | Long Beach | California | 90822 | — |
| Lycera Investigational Site | Mission Hills | California | 91345 | — |
| Lycera Investigational Site | Rialto | California | 92377 | — |
| Lycera Investigational Site | Hollywood | Florida | 33021 | — |
| Lycera Investigational Site | Miami | Florida | 33176 | — |
| Lycera Investigational Site | Decatur | Georgia | 30033 | — |
| Lycera Investigational Site | Marietta | Georgia | 30060 | — |
| Lycera Investigational Site | Chicago | Illinois | 60637 | — |
| Lycera Investigational Site | Louisville | Kentucky | 40202 | — |
| Lycera Investigational Site | Baton Rouge | Louisiana | 70809 | — |
| Lycera Investigational Site | Ann Arbor | Michigan | 48109 | — |
| Lycera Investigational Site | Brooklyn | New York | 11230 | — |
| Lycera Investigational Site | New York | New York | 10024 | — |
| Lycera Investigational Site | The Bronx | New York | 10461 | — |
| Lycera Investigational Site | Greenville | North Carolina | 27834 | — |
| Lycera Investigational Site | Flourtown | Pennsylvania | 19031 | — |
| Lycera Investigational Site | Philadelphia | Pennsylvania | 19104 | — |
| Lycera Investigational Site | Sayre | Pennsylvania | 18840 | — |
| Lycera Investigational Site | Nashville | Tennessee | 37212 | — |
| Lycera Investigational Site | Union City | Tennessee | 38261 | — |
| Lycera Investigational Site. | Houston | Texas | 76092 | — |
| Lycera Investigational Sites | Houston | Texas | 77004 | — |
| Lycera Investigational Site | Houston | Texas | 77004 | — |
| Lycera Investigational Site | Houston | Texas | 77030 | — |
| Lycera Investigational Site | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 45 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02762500, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 1, 2019 · Synced Sep 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02762500 live on ClinicalTrials.gov.